This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Inozyme Pharma, Inc., Westfaelische Wilhelms-Universitaet Muenster. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 19 Years Active: 2022
Title: Ashmita Saigal: Innovator in Myointimal Proliferation Treatment
Introduction
Ashmita Saigal is a notable inventor based in Stamford, CT (US). She has made significant contributions to the field of medical treatments, particularly in addressing myointimal proliferation. Her innovative approach has the potential to impact patient care positively.
Latest Patents
Ashmita holds a patent for "Methods of treating myointimal proliferation." This invention provides a method of treating myointimal proliferation by administering a recombinant human soluble ectonucleotide pyrophosphatase phosphodiesterase (hsNPP1), active fragment, or fusion protein thereof. This advancement showcases her commitment to developing effective medical solutions.
Career Highlights
Throughout her career, Ashmita has worked with prominent organizations, including Inozyme Pharma, Inc. and Westfaelische Wilhelms-Universitaet Muenster. Her experience in these institutions has allowed her to refine her skills and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Yan Yan and Anumeha Shah. Their collaborative efforts have likely enhanced the quality and impact of her work in the field.
Conclusion
Ashmita Saigal's contributions to the treatment of myointimal proliferation highlight her innovative spirit and dedication to improving healthcare. Her patent and career achievements reflect her significant role in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile